Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

Plasma Copeptin and the Risk of Diabetes Mellitus

Sofia Enhörning, Thomas J. Wang, Peter M. Nilsson et al. · Circulation · 2010 · 297 citations · Full text

Medicine, Endocrinology, Diabetology +10

Selected Contribution: Sex differences in osmotic regulation of AVP and renal sodium handling

Nina S. Stachenfeld, Andres E. Splenser, Wendy L. Calzone et al. · Journal of Applied Physiology · 2001 · 190 citations

Medicine, Endocrinology, Physiology +17

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

Sofia Enhörning, Lise Bankir, Nadine Bouby et al. · International Journal of Obesity · 2012 · 190 citations · Full text

Medicine, Endocrinology, Physiology +8